Navigation Links
New genetic link found between normal fetal growth and cancer
Date:4/8/2013

Two researchers at the National Institutes of Health discovered a new genetic link between the rapid growth of healthy fetuses and the uncontrolled cell division in cancer. The findings shed light on normal development and on the genetic underpinnings of common cancers.

The work, conducted using mouse and human tissue, appears in today's issue of the Proceedings of the National Academy of Sciences. The authors, Julian C. Lui, Ph.D., and Jeffrey Baron, M.D., work at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

"We've long known that some of the genes that promote rapid growth in prenatal and early postnatal life become reactivated in cancer cells," said Dr. Baron. "Now we've identified a molecular switch that appears to turn on some of these genes, taking us a step forward in understanding normal body growth and the abnormal growth in some types of cancer."

Before birth, a team of more than 200 growth-promoting genes is highly active, fueling the fetus' explosive growth. After birth, these genes are gradually switched off, apparently to slow body growth as we age and approach adult size. In cancer cells, some of these genes can be switched back on.

One of the major growth-promoting genes is called IGF2. This gene is critical for normal prenatal body growth and is reactivated in many types of cancer, showing remarkably high activity in bladder and prostate cancer and some childhood cancers.

For years, scientists did not know what turned IGF2 on and off. Now, using a variety of techniques and tissue types, Drs. Lui and Baron found evidence that a protein known as E2F3 activates the IGF2 gene in normal development and in cancerin particular, in bladder and metastatic prostate cancers.

More broadly, E2F3 appears to regulate not just IGF2, but also many other genes on the body-growth team. When E2F3 levels are high, these genes are active. When E2F3 takes a dive, so do these genes. The upshot is that E2F3 may function as one of the master switches that limit body growth. As such, it is of great interest as researchers seek to understand the complex genetic choreography responsible for normal growth and the diseases that result when it goes awry.


'/>"/>

Contact: Alisa Machalek
alisa.machalek@nih.gov
NIH/National Institute of General Medical Sciences
Source:Eurekalert

Related biology news :

1. Couch potatoes may be genetically predisposed to being lazy, MU study finds
2. Symposium highlights epigenetic effects of milk
3. Genetics Society of Americas Genetics journal highlights for April 2013
4. Researchers discover brain cancer treatment using genetic material from bone marrow cells
5. Study finds strong genetic component to childhood obesity
6. Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival
7. Genetic analysis saves major apple-producing region of Washington state
8. Epigenetics studies take root in plants
9. Genetic analysis calls for the protection of 2 highly endangered Portuguese fish species
10. New database to speed genetic discoveries
11. Researchers divide enzyme to conquer genetic puzzle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... ... September 21, 2017 , ... Biorez, Inc. , ... Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve as an Independent ... tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is designed to stabilize ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... that it has appointed Vishwas Paralkar to the role of chief scientific officer. ... technology. He will report to Cybrexa’s president and CEO, Per Hellsund. , “I ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... global provider of engineering, architecture, project controls, construction management, commissioning and qualification ... announced the unveiling of the iCON™ brand which represents the collective facility ...
(Date:9/20/2017)... , ... September 20, 2017 ... ... published findings of a study examining the effects of exoskeleton-assisted walking on ... cord injury (SCI). The article, "Neuromechanical adaptations during a robotic powered exoskeleton ...
Breaking Biology Technology: